Concepedia

Hao Guo

HG

33

Publications

3.2K

Citations

22

H-Index

2004

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Massachusetts General Hospital

Brigham and Women's Hospital

Memorial Sloan Kettering Cancer Center

Harvard University

Hao Guo is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2004–2024

33

Publications

33

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

Sara M. Tolaney, William T. Barry, Chau T. Dang et al. · New England Journal of Medicine · 2015 · 731 citations · Full text

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Shaokun Shu, Charles Y. Lin, Housheng Hansen He et al. · Nature · 2016 · 616 citations · Full text

, , +9

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Sara M. Tolaney, Hao Guo, Sònia Pernas et al. · Journal of Clinical Oncology · 2019 · 276 citations · Full text

Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer

Daniel G. Stover, Heather A. Parsons, Gavin Ha et al. · Journal of Clinical Oncology · 2018 · 230 citations · Full text

, , +15

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

Daniel G. Stover, Carlos R. Gil Del Alcazar, Jane Brock et al. · npj Breast Cancer · 2018 · 142 citations · Full text

Rows per page

1–5 of 33